These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36347832)

  • 21. Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.
    Williams MS; Basma NJ; Amaral FMR; Wiseman DH; Somervaille TCP
    BMC Cancer; 2021 Oct; 21(1):1153. PubMed ID: 34711181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cephalotaxine Inhibits the Survival of Leukemia Cells by Activating Mitochondrial Apoptosis Pathway and Inhibiting Autophagy Flow.
    Liu T; Guo Q; Zheng S; Liu Y; Yang H; Zhao M; Yao L; Zeng K; Tu P
    Molecules; 2021 May; 26(10):. PubMed ID: 34070111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of autophagy in targeted therapy for acute myeloid leukemia.
    Du W; Xu A; Huang Y; Cao J; Zhu H; Yang B; Shao X; He Q; Ying M
    Autophagy; 2021 Oct; 17(10):2665-2679. PubMed ID: 32917124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autophagy Proteins ATG5 and ATG7 Are Essential for the Maintenance of Human CD34(+) Hematopoietic Stem-Progenitor Cells.
    Gomez-Puerto MC; Folkerts H; Wierenga AT; Schepers K; Schuringa JJ; Coffer PJ; Vellenga E
    Stem Cells; 2016 Jun; 34(6):1651-63. PubMed ID: 26930546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockdown of BNIP3L or SQSTM1 alters cellular response to mitochondria target drugs.
    Rodrigo R; Mendis N; Ibrahim M; Ma C; Kreinin E; Roma A; Berg S; Blay J; Spagnuolo PA
    Autophagy; 2019 May; 15(5):900-907. PubMed ID: 30563411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Casein kinase 1α inhibits p53 downstream of MDM2‑mediated autophagy and apoptosis in acute myeloid leukemia.
    Xu W; Huang Z; Gan Y; Chen R; Huang Y; Xue B; Jiang S; Yu Z; Yu K; Zhang S
    Oncol Rep; 2020 Nov; 44(5):1895-1904. PubMed ID: 32901886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The combination of a histone deacetylase inhibitor with the BH3-mimetic GX15-070 has synergistic antileukemia activity by activating both apoptosis and autophagy.
    Wei Y; Kadia T; Tong W; Zhang M; Jia Y; Yang H; Hu Y; Viallet J; O'Brien S; Garcia-Manero G
    Autophagy; 2010 Oct; 6(7):976-8. PubMed ID: 20729640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in
    Jiang X; Mak PY; Mu H; Tao W; Mak DH; Kornblau S; Zhang Q; Ruvolo P; Burks JK; Zhang W; McQueen T; Pan R; Zhou H; Konopleva M; Cortes J; Liu Q; Andreeff M; Carter BZ
    Clin Cancer Res; 2018 May; 24(10):2417-2429. PubMed ID: 29463558
    [No Abstract]   [Full Text] [Related]  

  • 29. A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia.
    Chiarini F; Lonetti A; Teti G; Orsini E; Bressanin D; Cappellini A; Ricci F; Tazzari PL; Ognibene A; Falconi M; Pagliaro P; Iacobucci I; Martinelli G; Amadori S; McCubrey JA; Martelli AM
    Oncotarget; 2012 Dec; 3(12):1615-28. PubMed ID: 23271044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Idarubicin induces mTOR-dependent cytotoxic autophagy in leukemic cells.
    Ristic B; Bosnjak M; Arsikin K; Mircic A; Suzin-Zivkovic V; Bogdanovic A; Perovic V; Martinovic T; Kravic-Stevovic T; Bumbasirevic V; Trajkovic V; Harhaji-Trajkovic L
    Exp Cell Res; 2014 Aug; 326(1):90-102. PubMed ID: 24907655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of Quercetin-Induced Apoptosis by Cotreatment with Autophagy Inhibitor Is Associated with Augmentation of BAK-Dependent Mitochondrial Pathway in Jurkat T Cells.
    Ha EJ; Kim KY; Kim CE; Jun DY; Kim YH
    Oxid Med Cell Longev; 2019; 2019():7989276. PubMed ID: 31827702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cotargeting BCL-2 and PI3K Induces BAX-Dependent Mitochondrial Apoptosis in AML Cells.
    Rahmani M; Nkwocha J; Hawkins E; Pei X; Parker RE; Kmieciak M; Leverson JD; Sampath D; Ferreira-Gonzalez A; Grant S
    Cancer Res; 2018 Jun; 78(11):3075-3086. PubMed ID: 29559471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restoration of Autophagic Flux Rescues Oxidative Damage and Mitochondrial Dysfunction to Protect against Intervertebral Disc Degeneration.
    Kang L; Xiang Q; Zhan S; Song Y; Wang K; Zhao K; Li S; Shao Z; Yang C; Zhang Y
    Oxid Med Cell Longev; 2019; 2019():7810320. PubMed ID: 31976028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A New Strategy to Target Acute Myeloid Leukemia Stem and Progenitor Cells Using Chidamide, a Histone Deacetylase Inhibitor.
    Li Y; Chen K; Zhou Y; Xiao Y; Deng M; Jiang Z; Ye W; Wang X; Wei X; Li J; Liang J; Zheng Z; Yao Y; Wang W; Li P; Xu B
    Curr Cancer Drug Targets; 2015; 15(6):493-503. PubMed ID: 26282548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-1β inhibits self-renewal capacity of dormant CD34⁺/CD38⁻ acute myelogenous leukemia cells in vitro and in vivo.
    Yang J; Ikezoe T; Nishioka C; Nobumoto A; Yokoyama A
    Int J Cancer; 2013 Oct; 133(8):1967-81. PubMed ID: 23564444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nicotinamide phosphoribosyltransferase inhibitors selectively induce apoptosis of AML stem cells by disrupting lipid homeostasis.
    Subedi A; Liu Q; Ayyathan DM; Sharon D; Cathelin S; Hosseini M; Xu C; Voisin V; Bader GD; D'Alessandro A; Lechman ER; Dick JE; Minden MD; Wang JCY; Chan SM
    Cell Stem Cell; 2021 Oct; 28(10):1851-1867.e8. PubMed ID: 34293334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-143 sensitizes acute myeloid leukemia cells to cytarabine via targeting ATG7- and ATG2B-dependent autophagy.
    Zhang H; Kang J; Liu L; Chen L; Ren S; Tao Y
    Aging (Albany NY); 2020 Oct; 12(20):20111-20126. PubMed ID: 33077697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein Kinase C Epsilon Is a Key Regulator of Mitochondrial Redox Homeostasis in Acute Myeloid Leukemia.
    Di Marcantonio D; Martinez E; Sidoli S; Vadaketh J; Nieborowska-Skorska M; Gupta A; Meadows JM; Ferraro F; Masselli E; Challen GA; Milsom MD; Scholl C; Fröhling S; Balachandran S; Skorski T; Garcia BA; Mirandola P; Gobbi G; Garzon R; Vitale M; Sykes SM
    Clin Cancer Res; 2018 Feb; 24(3):608-618. PubMed ID: 29127121
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of mTOR-dependent autophagy sensitizes leukemic cells to cytarabine-induced apoptotic death.
    Bosnjak M; Ristic B; Arsikin K; Mircic A; Suzin-Zivkovic V; Perovic V; Bogdanovic A; Paunovic V; Markovic I; Bumbasirevic V; Trajkovic V; Harhaji-Trajkovic L
    PLoS One; 2014; 9(4):e94374. PubMed ID: 24714637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine.
    Buettner R; Nguyen LXT; Morales C; Chen MH; Wu X; Chen LS; Hoang DH; Hernandez Vargas S; Pullarkat V; Gandhi V; Marcucci G; Rosen ST
    J Hematol Oncol; 2021 Apr; 14(1):70. PubMed ID: 33902674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.